Charles Schwab Investment Management Inc Arcturus Therapeutics Holdings Inc. Transaction History

Charles Schwab Investment Management Inc

  • $527 Billion
  • Q4 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 207,802 shares of ARCT stock, worth $2.68 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
207,802
Previous 197,622 5.15%
Holding current value
$2.68 Million
Previous $4.59 Million 23.11%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025
BUY
$14.82 - $25.48 $150,867 - $259,386
10,180 Added 5.15%
207,802 $3.53 Million
Q3 2024

Nov 12, 2024
BUY
$18.08 - $25.38 $58,289 - $81,825
3,224 Added 1.66%
197,622 $4.59 Million
Q2 2024

Aug 12, 2024
BUY
$24.35 - $44.39 $88,439 - $161,224
3,632 Added 1.9%
194,398 $4.73 Million
Q1 2024

May 08, 2024
BUY
$31.23 - $42.99 $139,160 - $191,563
4,456 Added 2.39%
190,766 $6.44 Million
Q4 2023

Feb 06, 2024
BUY
$17.71 - $32.97 $41,954 - $78,105
2,369 Added 1.29%
186,310 $5.87 Million
Q3 2023

Nov 08, 2023
BUY
$25.44 - $37.35 $138,266 - $202,997
5,435 Added 3.04%
183,941 $4.7 Million
Q2 2023

Aug 09, 2023
SELL
$23.94 - $32.36 $20,827 - $28,153
-870 Reduced 0.49%
178,506 $5.12 Million
Q1 2023

May 11, 2023
BUY
$14.72 - $23.97 $12,144 - $19,775
825 Added 0.46%
179,376 $4.3 Million
Q4 2022

Feb 13, 2023
BUY
$14.14 - $23.06 $109,259 - $178,184
7,727 Added 4.52%
178,551 $3.03 Million
Q3 2022

Nov 14, 2022
BUY
$13.05 - $22.13 $190,086 - $322,345
14,566 Added 9.32%
170,824 $2.53 Million
Q2 2022

Aug 15, 2022
BUY
$12.26 - $31.17 $20,927 - $53,207
1,707 Added 1.1%
156,258 $2.46 Million
Q1 2022

May 13, 2022
BUY
$17.64 - $39.57 $65,338 - $146,567
3,704 Added 2.46%
154,551 $4.17 Million
Q4 2021

Feb 11, 2022
BUY
$34.2 - $47.56 $44,015 - $61,209
1,287 Added 0.86%
150,847 $5.58 Million
Q3 2021

Nov 16, 2021
BUY
$27.88 - $58.25 $137,699 - $287,696
4,939 Added 3.42%
149,560 $7.15 Million
Q2 2021

Aug 16, 2021
BUY
$25.79 - $42.11 $157,190 - $256,660
6,095 Added 4.4%
144,621 $4.89 Million
Q1 2021

May 17, 2021
BUY
$38.75 - $86.92 $104,470 - $234,336
2,696 Added 1.98%
138,526 $5.72 Million
Q4 2020

Feb 16, 2021
BUY
$34.61 - $123.66 $650,252 - $2.32 Million
18,788 Added 16.05%
135,830 $5.89 Million
Q3 2020

Nov 13, 2020
BUY
$37.49 - $63.19 $3.13 Million - $5.27 Million
83,449 Added 248.41%
117,042 $5.02 Million
Q2 2020

Aug 14, 2020
BUY
$12.66 - $58.27 $425,287 - $1.96 Million
33,593 New
33,593 $1.57 Million

Others Institutions Holding ARCT

# of Institutions
168
Shares Held
26M
Call Options Held
163K
Put Options Held
173K
View Full List

About Arcturus Therapeutics Holdings Inc.

ARCT Quotes by TradingView
  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $342M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email